Assessing the Validity of Clinician Advice That Patients Avoid Use of Topical Agents Before Daily Radiotherapy Treatments | Zendy

Brian C. Baumann | Zendy; Ioannis I. Verginadis | Zendy; Chuan Zeng | Zendy; Brett I. Bell | Zendy; Sravya Koduri | Zendy; Carolyn Vachani | Zendy; Kelly M. MacArthur | Zendy; Timothy D. Solberg | Zendy; Constantinos Koumenis | Zendy; James M. Metz | Zendy

Open Access

Assessing the Validity of Clinician Advice That Patients Avoid Use of Topical Agents Before Daily Radiotherapy Treatments

Author(s) -

Brian C. Baumann,

Ioannis I. Verginadis,

Chuan Zeng,

Brett I. Bell,

Sravya Koduri,

Carolyn Vachani,

Kelly M. MacArthur,

Timothy D. Solberg,

Constantinos Koumenis,

James M. Metz

Publication year - 2018

Publication title -

jama oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 8.846

H-Index - 99

eISSN - 2374-2445

pISSN - 2374-2437

DOI - 10.1001/jamaoncol.2018.4292

Subject(s) - medicine , silver sulfadiazine , radiation therapy , topical agents , dermatology , surgery , wound healing

Radiation dermatitis is common and often treated with topical therapy. Patients are typically advised to avoid topical agents for several hours before daily radiotherapy (RT) out of concern that topical agents might increase the radiation dose to the skin. With modern RT's improved skin-sparing properties, this recommendation may be irrelevant.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research